IL-6 trans-signaling in a humanized mouse model of scleroderma.
IL-6 trans-signaling in a humanized mouse model of scleroderma.
复制标题
DOI:
10.1073/pnas.2306965120
复制
发表时间:
2023-09-12
影响因子:
11.1
通讯作者:
Flavell, Richard A.
中科院分区:
文献类型:
--
作者:
Odell, Ian D.;Agrawal, Kriti;Sefik, Esen;Odell, Anahi V.;Caves, Elizabeth;Kirkiles-Smith, Nancy C.;Horsley, Valerie;Hinchcliff, Monique;Pober, Jordan S.;Kluger, Yuval;Flavell, Richard A.
Scleroderma is an autoimmune disease that causes skin and internal organ fibrosis. No mouse model has been identified that fully recapitulates human disease. Therefore, we tested whether the MISTRG6 strain of humanized mice could be transplanted with healthy or scleroderma human skin grafts. We found that healthy and scleroderma skin grafts retained skin and bone marrow–derived immune cells. Moreover, fibrosis in scleroderma skin grafts was alleviated by engraftment with unmatched allogeneic hematopoietic stem cells. Mechanistic studies supported a trans-signaling model whereby CD4 T cell–derived soluble interleukin-6 (IL-6) receptor complexed with interferon-driven IL-6 cytokine drives skin fibrosis. Thus, scleroderma skin transplants to MISTRG6 humanized mice recapitulate a key signaling pathway of scleroderma and may be a useful model to study human disease. Fibrosis is regulated by interactions between immune and mesenchymal cells. However, the capacity of cell types to modulate human fibrosis pathology is poorly understood due to lack of a fully humanized model system. MISTRG6 mice were engineered by homologous mouse/human gene replacement to develop an immune system like humans when engrafted with human hematopoietic stem cells (HSCs). We utilized MISTRG6 mice to model scleroderma by transplantation of healthy or scleroderma skin from a patient with pansclerotic morphea to humanized mice engrafted with unmatched allogeneic HSC. We identified that scleroderma skin grafts contained both skin and bone marrow–derived human CD4 and CD8 T cells along with human endothelial cells and pericytes. Unlike healthy skin, fibroblasts in scleroderma skin were depleted and replaced by mouse fibroblasts. Furthermore, HSC engraftment alleviated multiple signatures of fibrosis, including expression of collagen and interferon genes, and proliferation and activation of human T cells. Fibrosis improvement correlated with reduced markers of T cell activation and expression of human IL-6 by mesenchymal cells. Mechanistic studies supported a model whereby IL-6 trans-signaling driven by CD4 T cell–derived soluble IL-6 receptor complexed with fibroblast-derived IL-6 promoted excess extracellular matrix gene expression. Thus, MISTRG6 mice transplanted with scleroderma skin demonstrated multiple fibrotic responses centered around human IL-6 signaling, which was improved by the presence of healthy bone marrow–derived immune cells. Our results highlight the importance of IL-6 trans-signaling in pathogenesis of scleroderma and the ability of healthy bone marrow–derived immune cells to mitigate disease.
登录
查看更多内容
影响因子:
4.7
作者:
Assassi, Shervin;del Junco, Deborah;Sutter, Kari;McNearney, Terry A.;Reveille, John D.;Karnavas, Andrew;Gourh, Pravitt;Estrada-Y-Martin, Rosa M.;Fischbach, Michael;Arnett, Frank C.;Mayes, Maureen D.
通讯作者:
Mayes, Maureen D.
影响因子:
3
作者:
IHN, H;SATO, S;TAKEHARA, K
通讯作者:
TAKEHARA, K
影响因子:
46.9
作者:
Fischer, M;Goldschmitt, J;RoseJohn, S
通讯作者:
RoseJohn, S
影响因子:
27.4
作者:
Eloranta, Maija-Leena;Franck-Larsson, Karin;Ronnblom, Lars
通讯作者:
Ronnblom, Lars
影响因子:
2.2
作者:
Chua, Siang Ling;Too, Wei Cun See;Few, Ling Ling
通讯作者:
Few, Ling Ling